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Purpose: Even in cases of positive evidence for complementary medicine (CM) therapies, it
is still difficult for cancer patients to identify reputable providers. The aim of this study was
to develop and evaluate a criteria list to provide guidance to cancer patients seeking
a reputable CM provider.
Methods: The design combined a literature review, an expert consensus procedure (n=15)
and an assessment from three stakeholder perspectives (patients (n=18), CM providers
(n=26) and oncology physicians (n=20)).
Results: A total of 30 existing CM criteria were extracted from the literature, and 12 more
were added by the experts. The main challenge was to define criteria that could easily be
applied by the patients. A final comprehensive list of 8 criteria guiding cancer patients to find
a reputable CM provider was developed.
Conclusion: Health professionals and cancer information services might find the criteria list
helpful when aiming to strengthen patients’ awareness of quality-related factors associated
with CM providers. The criteria developed might be helpful when standards are established
for quality assurance in CM in oncology.
Keywords: neoplasms, complementary medicine, patient-centered care, standards,
healthcare quality assurance
Background
Approximately half of cancer patients use complementary medicine (CM) during
their cancer treatment,1 and that percentage has appeared to increase over time.2
The term CM summarizes a broad range of heterogeneous therapies such as yoga,
relaxation techniques, herbal medicine or whole traditional systems such as tradi-
tional Chinese medicine, many of which lack sufficient data or clinical evidence.
A recent retrospective observational study using data from the American National
Cancer Database3 suggested that CM provided by nonmedical personnel was
associated with a higher risk of death due to declined cancer treatments. These
findings have been vigorously challenged for the validity of its conclusion due to
sampling and data issues.4 Nevertheless, the publication highlights the need to
involve medical personnel to guide patients when they want to use CM. In
particular, there is an increasing body of positive evidence for some therapies,
such as yoga to reduce fatigue and sleep disturbances5 or mindfulness-based stress
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reduction (MBSR)6 to improve quality of life and mood
symptoms which is reflected in existing medical
guidelines.7,8
The evidence for the quality of CM offers is often difficult
to judge for patients and physicians without experience in
CM. The lack of standards and regulations for nonmedical
CM providers (providers without a medical license) in some
countries and the fact that they are usually not part of the
oncology care team make this process even more difficult.
Some hospitals and private practices offer in-house CM pro-
grams to ensure the quality of their interventions; however,
this approach is not considered standard. Therefore, patients
may sometimes feel alone when searching for reputable non-
medical providers for CM therapies. Even when patients try to
follow their oncology physicians’ evidence-based CM recom-
mendations, they are still unsure which providers offer both
safety and high quality. Therefore, a need exists to discrimi-
nate between more and less “safe” nonmedical CM providers.
As part of the Competence Network Complementary
Medicine in Oncology (KOKON),9 a collaborative research
project in Germany funded by the German Cancer Aid
(grant 70112369), this project aims to develop CM criteria
as indicators of reputable CM providers in oncology.
Method
The design (see Figure 1: Flowchart of the criteria list
development process) included a systematic literature
review (Phase I) to identify existing criteria for reputable
CM providers. This process was followed by an interna-
tional and interprofessional expert consensus procedure
(Phase II) and a practice evaluation with relevant stake-
holder groups (cancer patients, CM providers and oncology
physicians). Experts recruited for this study were based in
Germany and Switzerland, and from diverse backgrounds
(medical oncology, primary care, psychology, psycho-
oncology, nursing, pediatric oncology, law, statutory health
insurance, patient advocacy/patient representation, research
methodology, public health, and epidemiology). Oral
informed consent was provided by the participating experts,
patients provided written informed consent and the other
survey participants were informed about the aim of the
project and that if they completed the survey, their answers
were anonymous.
Phase I – Literature Review
Literature Inclusion and Exclusion Criteria
Publications were included from scientific journals, working
papers, and theses. Additionally, information materials,
websites and other types of publications addressing criteria
and standards for reputable CMproviders for cancer patients,
physicians, CM providers and leaders of cancer support
groups were included. Publications were excluded if the
stated criteria were in the context of neither oncology nor
CM, or the publication was not available in the English or
German language. Publications were not restricted by year of
publication.
Search Strategy
Electronic databases (Ovid MEDLINE, CENTRAL,
EMBASE and Web of Science) were searched from June
until August 31, 2017. We linked the following keywords
and text words and, if possible, combined them with sub-
ject headings: professional field related to complementary
and integrative oncology (integrative oncology, OR oncol-
ogy AND complementary medicine OR integrative medi-
cine) AND elements of quality assurance (criteria OR
standard OR quality OR safety) AND/OR profession (pro-
vid* OR health professional OR physician). Our search
strategy included all types of publications and research
designs. In addition, members of the expert consensus
procedure were asked to provide additional literature,
especially gray and/or unpublished literature. Moreover,
we searched the web using the same terms for websites
and materials that provide information on how to choose
reputable CM providers.
Selection of Studies and Data Extraction
One reviewer (AAR) searched the literature reviewing the
results thoroughly by assessing titles and abstracts (if
possible depending on the type of publication).
Publications were excluded if they did not mention any
criteria. Full text copies were generated from the resulting
literature, assessed and data extracted by one reviewer
(AAR). The study selection and data extraction were
supervised by a methodologist (CMW). Criteria were
then derived from qualitative analysis. Therefore, aquali-
tative content analysis according to Flick10 was performed.
Two independent reviewers (AAR, CMW) extracted cri-
teria. Content units were identified to cluster the selected
criteria using inductive coding strategies. Moreover, an
intersubjective validation of the coding by the two
reviewers to verify the reliability of the data was con-
ducted. Based on this, criteria themes were developed
and discussed within the team (education and training,
medical approach, attitude, cost and reimbursement).
Criteria were categorized by both reviewers independently,
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and any discrepancies considering categorization were
documented and resolved via discussion.
Phase II – Expert Consensus Procedure
Including an Evaluation on Three
Different Levels
A three-round expert consensus procedure was performed.
Experts (n=15) were invited to participate in this study by
email explaining the aim of this project. This group of experts
discussed, developed and redefined existing criteria from the
literature search in multiple rounds. In the first two rounds,
online surveys were completed, followed by conference calls
and written exchange to find consensus.
In a first survey, the experts indicated the importance of the
criteria found in the literature on a 0–10 Numeric Rating Scale
(NRS, 0 = “not important at all” to 10 = “fully important”).
The summarized results were discussed in a conference call,
and the criteria were revised accordingly. In the second survey,




Expert consensus procedure 
Conference call to discuss 
summarized results 
Conference call to finalize criteria 
for evaluation phase 
 pilot leaflet 
Phase III
Evaluation of the leaflet pilot version 
Round 1
Online survey of the rating on 
the importance of criteria from 
the literature 
Round 2
Online survey for the judgement 
on accessibility and relevance of 
remaining criteria 
Final expert conference call  
 final criteria list 
(see Fig. 3)
Figure 1 Flowchart of the criteria list development process.
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(open access = the information is easily accessible eg during
consultation the patient can ask the provider, provider has to be
asked, provider has to be observed) and relevance (NRS 0–10;
0 = “not relevant at all” to 10 = “very relevant”). Furthermore,
experts indicated the necessity (mandatory, optional or unne-
cessary) of each criterion for patients, physicians and an
optional future registry (as an obligation tool for CM provi-
ders). This registry could serve as a quality assurance system
in order to identify reputable CM providers. As a predefined
threshold, 50% of the experts had to find a criterion relevant to
a certain group (patient, physician, registry level) to keep it on
the list, and two-thirds had to indicate that the criterion was
mandatory to make it necessary for the resulting criteria list.
This multilayer process was followed by a second conference
call finalizing the criteria for the practice evaluation.
Furthermore, an introductory text and a disclaimer
were prepared to provide context to cancer patients when
they read the final leaflet. This approach was approved by
the expert group.
For the practice evaluation, the developed leaflet was
sent to cancer patients, oncology physicians and CM pro-
viders based in Germany. Cancer patients and oncology
physicians were recruited within the ongoing KOKON-
KTO study (Trial registration number: DRKS00012704).
CM providers were recruited by newsletters of profes-
sional associations in the field of yoga, naturopathy, acu-
puncture and MBSR.
Using an online survey or hard copies, 24 questions
(NRS 0–10 Likert scale: 0 = “don’t agree at all” to 10 =
“fully agree”) on the importance and usefulness of the
criteria were asked. Open-ended fields allowed survey
participants to provide additional feedback.
The evaluation results were discussed during two more
conference calls with the expert group, and a final criteria
list, including the introductory text and a disclaimer for
cancer patients, was agreed upon.
Data from the online surveys were analyzed using
descriptive statistics. The best practices in consensus methods
were informed by Murphy et al.11 The study was approved by




From the literature search (Phase I), 13 articles from data-
bases and the internet describing criteria for reputable CM
providers in oncology were revealed, and two more articles
from the experts were included (see Figure 2: Flowchart for
literature search and study selection). A total of 30 existing
CM criteria were extracted. The criteria (see Table 1: cri-
teria for reputable providers from the literature) were cate-
gorized into four dominant themes, namely, education and
training,12–22 medical approach,12,13,15-17,19–21,23–26
attitude12–15,20–23 and cost and reimbursement,12–16,21,22
which were used as the basis for the subsequent expert
consensus procedure. Most articles were developed for
patient use, and only one-third of the articles addressed
physicians, CM providers and others. The only detailed
criteria lists addressed the training of CM providers.
Criteria lists were usually developed from an insurance
perspective or for memberships of professional associa-
tions. No criteria list purely supported health professionals
and/or consulting services in recommending nonmedical
CM providers.
Phase II – Expert Consensus Procedure
and Evaluation
The 30 criteria resulting from the literature search were
merged into 27 after the elimination of duplicate criteria.
The first survey provided feedback from all experts, and
26 criteria (with the exception of one criterion, namely,
membership in a professional association) were rated as
highly important (median: 9–10 on the NRS; mean:
7.4–10). In the following conference call, when discussing
the survey results, participants agreed upon the criteria as
necessary and applicable to a German-speaking target
group. Additionally, two criteria were deleted for reasons
of redundancy, but 12 new criteria were added to the list.
In the second survey from the available 36 criteria, 23
were seen as mandatory for informing patients, 28 seemed
relevant for physicians, and 14 were viewed as necessary
for a possible registry (see Appendix 1: Results of the 2nd
survey of the expert consensus procedure). Furthermore, it
was decided to focus on the criteria list for guiding
patients in this project. In the following conference call,
the criteria were merged, rephrased and brought into an
order, resulting in a list of 10 criteria. During the discus-
sion, experts agreed that although some of the criteria are
important, they are difficult to verify by patients.
Furthermore, the introductory text and the disclaimer for
the patient leaflet were discussed and revised, and
a consented pilot version of the leaflet was developed.
In the third phase, the leaflet was evaluated by cancer
patients (n = 18), oncology physicians (n = 20) and CM
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providers (yoga instructors (n = 10), MBSR instructors (n
= 7), naturopathic physicians (n = 6), and physicians
trained in acupuncture (n = 3)). Most of the CM providers
(88.5%) regularly applied CM treatments, and two-thirds
(65.4%) regularly treated cancer patients. In general, and
independent of their background, the stakeholders agreed





Records eligible for 
abstract analysis 
(n = 26)




included in qualitative 
synthesis (n = 13)
Records excluded by title 
screening (n = 104)
Records eligible for 
screening 
(n = 130)
Records excluded by abstract 
analysis (n = 8)
Records articles excluded by 
full-text assessment 
(n = 5)
Experts records included in 
qualitative synthesis 
(n = 2)
Records included in 
qualitative synthesis 
(n = 15)
Figure 2 Flowchart for literature search and study selection.
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that the developed criteria are important. However, three
aspects were mentioned: some criteria should be rephrased
to be more understandable for patients, some of the criteria
were seen as difficult to verify, and views differed on the
number of years of experience needed for treating cancer
patients. When discussing the evaluation results in the
final expert conference call, experts agreed on revising
the criteria for better understandability and separating the
three criteria that are difficult to verify (having adequate
training for the CM therapy, being experienced in treating
cancer patients, and participating in continuous training)
from the rest of the criteria. One criterion was split into
two criteria, which resulted in a final list of 8 mandatory
criteria and 3 optional criteria that are more difficult to
verify. In addition, the introductory text and the disclaimer
were revised (see Figure 3: Leaflet for patients without the
disclaimer).
Discussion
A comprehensive list of 8 criteria guiding cancer patients
to find a reputable CM provider was systematically devel-
oped in an international and interprofessional consensus
procedure. To our knowledge, this is the first consented
criteria list to provide helpful guidance to cancer patients
when seeking a CM provider.
The developed CM criteria might contribute to better
quality control and regulation of CM providers in oncology
care, which can help to ensure safe therapies for cancer
patients considering CM alongside their cancer treatment.
Our approach had the advantage of combining the current
Table 1 Criteria for Reputable CM Providers from the Literature
Education & Training Medical Approach Attitude Cost & Reimbursement
Further training and education after
graduation8,11,13,15,16,19
Using of medical methods
(anamnesis, diagnosis,
documentation)8–11
No polemical statements against
therapeutic alternatives8,18
orfurther CM therapies [10]
No disproportionate financial
demands8
Additional title, if applicable9,12,19 Diagnosis and treatment
plan are set before start
of treatment9,10,12,17
Medically prescribed conventional
medicines are taken into
account9,10,16
Treatment costs and possible
reimbursement costs are discussed
prior to the therapy9,10,12,17,18
Certificates and quality or association
seals9,12,20,21







Study degree or basic education11,18,20,22




No false pretense of prospects of
success8,10
Clinical training or experience13,18 Professionalism11,14 Possibilities and limitations of CM
treatment are shown9,11,16-18




Willingness to proof qualifications15 Therapy freedom16 Commitment to scientific-
oriented, empirical medicine16




Rejection of alternative medicine
with better evidence of orthodox
medicine16
Willingness to name empirical
knowledge (evidence) on CM
treatment8,12,17,18
Practical experience16
Special training in specific CM
treatment16
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information from the literature with expert knowledge to
develop the resulting list of criteria. Engaging international
experts from different professions with different perspectives
allowed for a comprehensive approach aimed at making the
criteria more applicable to all types of cancer patients with
different cancer entities, therefore facilitating increased
importance and generalizability. The criteria list was tested
with different stakeholder groups. Two potential user popula-
tions were included (cancer patients and oncology physi-
cians) to ensure understandability and acceptance in the
main target groups. In addition, as a third stakeholder
group, a range of CM providers (nonmedical CM providers
and medical doctors applying CM) provided their feedback.
However, a focus on three stakeholder groups, the experts
and participants involved in the evaluation might not
encompass the entire spectrum of perspectives, CM profes-
sions and cancer entities and stages. Criteria were selected
based on anonymous online surveys but also expert discus-
sions, hence, a detection bias due to the characteristics of the
participants or a reader bias in interpreting the results of the
online surveys based on the selection of experts might be
possible.Moreover, all experts and participants were based in
Germany and Switzerland. Adjustments and validations
might be necessary for usage in, for example, Asian or
African countries. All experts were selected and invited to
participate in the study by the study team. Overall they had
a broad range of expertise, although, their opinions about CM
varied widely in the group, all of them had addressed the
topic CM before. Moreover, cancer patients included due to
their participation in the KOKON-KTO study might not
Dear patient, 
Did your doctor recommend one or more complementary medicine therapies in addition to your cancer 
treatment? Are you unsure what to look out for when selecting providers of these therapies?  
The following criteria should help you to make a decision about suitable and reputable providers of 
complementary medicinel therapies. However, the fulfilment of the criteria cannot guarantee the reputability 
of the provider or the safety and effectiveness of the complementary medicine therapies and does not 
correspond to a certificate. Your own impression should supplement your decision basis.  
Reputable providers of complementary medicine can be identified on the basis of the 8 criteria described 
The provider should: 
1. ask for your diagnosis and previous as well as ongoing treatments. 
2. be prepared to talk to you about possible interactions between complementary medicine therapies and 
your cancer treatment. 
3. explain to you why this complementary medicine therapy in particular is recommended for you.  
4. present to you the possibilities and limitations of this complementary medicine therapy in a realistic and 
understandable way, be prepared to present previous experiences with this therapy and to communicate 
reliable data. 
5. discuss with you the goals, contents, duration and costs of the planned therapy and changes in the course 
as well as ways of possible reimbursement. 
6. give you a reasonable period to consider and allow you to freely choose or reject the suggested therapy. 
7. respect your decision for or against the complementary medicine therapy.  
8. provide you with a comprehensible invoice for the treatment. 
There are other important aspects, but they are more difficult to verify. If you would like to know this 
about the provider, you should ask for:  
• A specialist training (or special study curriculum) with a regulated length that has been completed 
and that only therapies that have been learned and are currently mastered are used 
• Regular further and advanced training courses attended 
• At least 2 years of experience in the treatment of cancer patients 
Figure 3 Leaflet for patients without the disclaimer.
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represent the whole scope of available patients. The literature
review focused on the search terms “integrative oncology”
and “complementary medicine” because they are frequently
used nowadays, not searching for “alternative medicine”
might be seen as a limitation.
Most criteria found in the literature are useful when dis-
cussing about the quality assurance of CM providers, but
would be very difficult to verify for patients, because the
information needed is not freely accessible. In the develop-
ment of a list with practical implications, only criteria that
could be examined by patients were included in the 8 manda-
tory criteria. However, as a result, all criteria addressing atti-
tudes had to be deleted. Those criteriamight be better placed in
structures (eg, registries) that include a contract of
obligation.15,27 Moreover, criteria such as the membership in
a professional organization were seen as important. However,
in many countries the providers of complementary therapies
are not well regulated and because of this, it is was not seen as
a broadly applicable criterion. In countries, where complemen-
tary therapies are well regulated and respective professional
organizations are implemented, this can be used as additional
criterion. This developed criteria list can be seen as a first step.
Future developments might be criteria lists for oncology phy-
sicians or health insurance companies for use in their colla-
borations with CM providers. Moreover, a future registry
could be established based on the CM criteria provided.
Being listed in this registry could function as a quality certifi-
cate for CM providers working with cancer patients. In addi-
tion, the impact of the current list for patients on outcomes
needs to be evaluated in a prospective study.
This project provides only one tool for a more
informed choice of patients. To ensure overall quality of
CM use in oncology, oncology physicians should be
trained in giving CM advice to cancer patients and to
support choosing supportive, evidence-based CM
therapies.28 Moreover, other health professionals such as
nurses, pharmacologists and psychooncologists should be
involved when informing cancer patients on CM therapies.
Trial Registration
This project is part of the KOKON-KTO study registered
as DRKS00012704 on the “German Clinical Trials
Register” (date of registration: August 28, 2017).
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